TMO vs XLI
Thermo Fisher Scientific Inc (TMO) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
XLI (XLI) common stock.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
XLI does not have a complete income-statement cache yet.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. XLI currently screens at market cap $0.
Not investment advice. Open the TMO and XLI stock pages for the full models.
Not investment advice.